Reported 29 days ago
The weight-loss treatment market is projected to introduce 16 new drugs by 2029, with the overall market for obesity treatments potentially reaching $200 billion by 2031. Analysts from Morningstar and Pitchbook note that this expansion is driven by the success of existing drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound, prompting competitors such as Amgen and Pfizer to pursue clinical trials for their own treatments. The competition is expected to lower drug prices as new entrants aim for market share.
Source: YAHOO